Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 08 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-5.18 Insider Own6.85% Shs Outstand52.33M Perf Week22.96%
Market Cap165.81M Forward P/E- EPS next Y-2.58 Insider Trans-0.21% Shs Float48.88M Perf Month59.60%
Income-271.42M PEG- EPS next Q-0.78 Inst Own80.30% Short Float / Ratio4.37% / 2.28 Perf Quarter42.34%
Sales0.00M P/S- EPS this Y27.92% Inst Trans2.91% Short Interest2.14M Perf Half Y-65.45%
Book/sh5.76 P/B0.55 EPS next Y44.04% ROA-42.69% Target Price5.25 Perf Year-56.11%
Cash/sh6.59 P/C0.48 EPS next 5Y12.40% ROE-69.42% 52W Range1.37 - 9.80 Perf YTD-55.87%
Dividend- P/FCF- EPS past 5Y-53.05% ROI-56.92% 52W High-67.76% Beta1.96
Dividend %- Quick Ratio4.96 Sales past 5Y0.00% Gross Margin- 52W Low130.66% ATR0.27
Employees112 Current Ratio4.96 Sales Q/Q- Oper. Margin0.00% RSI (14)68.69 Volatility10.75% 12.27%
OptionableYes Debt/Eq0.61 EPS Q/Q35.29% Profit Margin- Rel Volume0.87 Prev Close3.07
ShortableYes LT Debt/Eq0.58 EarningsNov 14 AMC Payout- Avg Volume935.06K Price3.16
Recom3.50 SMA2031.86% SMA5059.25% SMA200-26.10% Volume817,208 Change2.93%
Date Action Analyst Rating Change Price Target Change
Nov-17-23Upgrade CapitalOne Equal Weight → Overweight $7 → $12
Jul-27-23Downgrade UBS Buy → Neutral $15 → $4
Jul-25-23Downgrade JP Morgan Neutral → Underweight
Jul-25-23Downgrade Chardan Capital Markets Buy → Neutral
Jul-24-23Downgrade Jefferies Buy → Hold
Jul-24-23Downgrade CapitalOne Overweight → Equal Weight $7
Nov-15-22Initiated CapitalOne Overweight $24
Aug-02-22Downgrade Citigroup Neutral → Sell $6
Feb-24-22Downgrade JP Morgan Overweight → Neutral $90 → $21
Feb-11-22Initiated Goldman Buy $70
Nov-21-23 04:15PM
Nov-15-23 08:00AM
Nov-14-23 06:09PM
Nov-06-23 05:00AM
11:21PM Loading…
Nov-01-23 11:21PM
Oct-17-23 01:44AM
Oct-11-23 06:00AM
Sep-13-23 11:30AM
Sep-08-23 06:00AM
Sep-07-23 06:00AM
Aug-16-23 10:26AM
Aug-14-23 07:31PM
07:15AM Loading…
Aug-02-23 10:09AM
Jul-27-23 02:30AM
Jul-26-23 06:42AM
Jul-25-23 09:16AM
Jul-24-23 06:26AM
Jun-14-23 11:30AM
May-30-23 04:15PM
May-16-23 07:44AM
May-15-23 04:01PM
Apr-27-23 11:30AM
Apr-21-23 07:30AM
06:29AM Loading…
Apr-11-23 06:29AM
Apr-04-23 01:16PM
Apr-03-23 11:38AM
Mar-28-23 04:08PM
Mar-01-23 05:55AM
Feb-09-23 07:30AM
Jan-04-23 07:00AM
Dec-09-22 11:30AM
Nov-30-22 09:55AM
Nov-16-22 04:30PM
Nov-14-22 09:55AM
Nov-10-22 02:17PM
Nov-09-22 04:01PM
Nov-02-22 06:24AM
Sep-22-22 06:06AM
Sep-08-22 11:30AM
Sep-07-22 04:05PM
Aug-26-22 01:34PM
Aug-19-22 12:32PM
Aug-18-22 05:47PM
Aug-10-22 10:57AM
Aug-09-22 04:33PM
Aug-08-22 08:39AM
Aug-05-22 04:30PM
Aug-02-22 12:07PM
Jun-12-22 09:00AM
Jun-09-22 11:30AM
May-27-22 08:00AM
May-19-22 08:00AM
May-13-22 01:44PM
May-11-22 12:38PM
May-10-22 04:10PM
May-06-22 08:50AM
Apr-29-22 05:30AM
Mar-31-22 11:30AM
Mar-23-22 06:32PM
Mar-05-22 11:07AM
Mar-04-22 05:10AM
Mar-03-22 06:21PM
Mar-02-22 10:11AM
Mar-01-22 04:05PM
Feb-25-22 10:00AM
Feb-23-22 06:00PM
Feb-07-22 05:38PM
Feb-04-22 08:30PM
Feb-03-22 05:30AM
Jan-03-22 04:05PM
Dec-30-21 10:18AM
Dec-23-21 07:38AM
Dec-16-21 04:38PM
Nov-10-21 10:00AM
Nov-09-21 04:30PM
Nov-08-21 04:05PM
Oct-11-21 09:36AM
Sep-10-21 04:47PM
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BORGESON JOHN A.See RemarksJun 16Sale9.232,74925,373178,077Jun 16 08:25 PM
EHRLICH JASONSee RemarksJun 16Sale9.232,25820,84161,924Jun 16 08:27 PM
BORGESON JOHN A.See RemarksJun 14Sale9.421,44813,640175,332Jun 16 08:25 PM
EHRLICH JASONSee RemarksJun 14Sale9.421,13210,66358,688Jun 16 08:27 PM